Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Published:2001-01 Issue:1 Volume:15 Page:71-75
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Marzolini Catia,Telenti Amalio,Decosterd Laurent A.,Greub Gilbert,Biollaz Jérôme,Buclin Thierry

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference11 articles.

2. What are the perceived advantages and disadvantages of non-nucleoside reverse transcriptase inhibitors as first-line therapy?

3. Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Cited by 748 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of 1H Nuclear Magnetic Resonance Quantitative Method for Efavirenz API Quality Control;Current Analytical Chemistry;2024-11

2. Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics;ACS Pharmacology & Translational Science;2024-09-06

3. A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem;Exploration of Drug Science;2024-08-28

4. Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing;Frontiers in Bioscience-Landmark;2024-07-02

5. Quantification of Efavirenz Hydroxymetabolites in Human Plasma Using LC-HRMS/MS;Therapeutic Drug Monitoring;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3